AR and Familial prostate cancer: Initially, prostate cancers are androgen-sensitive (that is, they cease growing when deprived of androgens or when treated with androgen receptor antagonists, such as flutamide or bicalutamide), and therefore most patients respond to androgen ablation therapy.